These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 11729185)

  • 1. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy.
    Mayo LD; Dixon JE; Durden DL; Tonks NK; Donner DB
    J Biol Chem; 2002 Feb; 277(7):5484-9. PubMed ID: 11729185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified.
    Mayo LD; Seo YR; Jackson MW; Smith ML; Rivera Guzman J; Korgaonkar CK; Donner DB
    J Biol Chem; 2005 Jul; 280(28):25953-9. PubMed ID: 15843377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network.
    Mayo LD; Donner DB
    Trends Biochem Sci; 2002 Sep; 27(9):462-7. PubMed ID: 12217521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
    Zhou M; Gu L; Findley HW; Jiang R; Woods WG
    Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms.
    Freeman DJ; Li AG; Wei G; Li HH; Kertesz N; Lesche R; Whale AD; Martinez-Diaz H; Rozengurt N; Cardiff RD; Liu X; Wu H
    Cancer Cell; 2003 Feb; 3(2):117-30. PubMed ID: 12620407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.
    Mayo LD; Donner DB
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11598-603. PubMed ID: 11504915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN regulates Mdm2 expression through the P1 promoter.
    Chang CJ; Freeman DJ; Wu H
    J Biol Chem; 2004 Jul; 279(28):29841-8. PubMed ID: 15090541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage.
    Kandel ES; Skeen J; Majewski N; Di Cristofano A; Pandolfi PP; Feliciano CS; Gartel A; Hay N
    Mol Cell Biol; 2002 Nov; 22(22):7831-41. PubMed ID: 12391152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of zinc deficiency on Akt-Mdm2-p53 and Akt-p21 signaling axes in normal and malignant human prostate cells.
    Han CT; Schoene NW; Lei KY
    Am J Physiol Cell Physiol; 2009 Nov; 297(5):C1188-99. PubMed ID: 19657064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
    Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
    Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship of PTEN, Mdm2 and p53 expression in astrocytoma].
    Zhong XY; Sun YH; Chen YX
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):478-81. PubMed ID: 14575575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas.
    Singh B; Reddy PG; Goberdhan A; Walsh C; Dao S; Ngai I; Chou TC; O-Charoenrat P; Levine AJ; Rao PH; Stoffel A
    Genes Dev; 2002 Apr; 16(8):984-93. PubMed ID: 11959846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells.
    Chung TW; Lee YC; Ko JH; Kim CH
    Cancer Res; 2003 Jul; 63(13):3453-8. PubMed ID: 12839924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lyn tyrosine kinase inhibits nuclear export of the p53 tumor suppressor.
    Ren X; Cao C; Zhu L; Yoshida K; Kharbanda S; Weichselbaum R; Kufe D
    Cancer Biol Ther; 2002; 1(6):703-8. PubMed ID: 12642697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation.
    Liu JL; Sheng X; Hortobagyi ZK; Mao Z; Gallick GE; Yung WK
    Mol Cell Biol; 2005 Jul; 25(14):6211-24. PubMed ID: 15988030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex.
    Zhang C; Comai L; Johnson DL
    Mol Cell Biol; 2005 Aug; 25(16):6899-911. PubMed ID: 16055704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
    Ramaswamy S; Nakamura N; Vazquez F; Batt DB; Perera S; Roberts TM; Sellers WR
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2110-5. PubMed ID: 10051603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage induces MDMX nuclear translocation by p53-dependent and -independent mechanisms.
    Li C; Chen L; Chen J
    Mol Cell Biol; 2002 Nov; 22(21):7562-71. PubMed ID: 12370303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.
    Li DM; Sun H
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15406-11. PubMed ID: 9860981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.